Strengthening the European Chain of sUpply for next generation medical RadionuclidEs (SECURE)

镭-223是一种放射性同位素-放射性核素-用于治疗转移性癌症。其他放射性核素显示出希望，可以满足未来的需求，但在获得之前还需要面对几个重大挑战。为了解决这些问题，欧盟资助的SECURE项目将确定并利用现有资源开发新的放射性核素，特别是α和β放射性同位素。它旨在消除可持续生产的关键障碍，并为充分利用α和β粒子治疗提供指导和建议。此外，该项目将提供关键的经验教训，以处理升级和可持续生产同位素的问题。

Radium-223 is a radioactive isotope – radionuclide – used to treat metastatic cancer. Other radionuclides show promise and could meet future demand, but there are several major challenges to be faced before becoming available. To address these, the EU-funded SECURE project will identify and use existing resources for new radionuclides, especially alpha- and beta-emitting isotopes. It aims to remove crucial barriers to sustainable production and provide guidance and recommendations for fully exploiting alpha and beta particle therapy. In addition, the project will deliver key lessons learnt to deal with problems in upscaling and sustainably producing isotopes.